Related references
Note: Only part of the references are listed.Matrix metalloproteinases and their multiple roles in neurodegenerative diseases
Gary A. Rosenberg
LANCET NEUROLOGY (2009)
Distinct neuroinflammatory profile in post-mortem human Huntington's disease
Aurelio Silvestroni et al.
NEUROREPORT (2009)
Blood-brain barrier disruption in the striatum of rats treated with 3-nitropropionic acid
Joaquim Duran-Vilaregut et al.
NEUROTOXICOLOGY (2009)
Mechanisms of neurodegeneration in Huntington's disease
Joana M. Gil et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II
Alexandra Benchoua et al.
HUMAN MOLECULAR GENETICS (2008)
Induction of MMP-9 expression and endothelial injury by oxidative stress after spinal cord injury
Fengshan Yu et al.
JOURNAL OF NEUROTRAUMA (2008)
The blood-brain barrier in health and chronic neurodegenerative disorders
Berislav V. Zlokovic
NEURON (2008)
Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies
Luca Cucullo et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Matrix metalloproteinase-9 deficiency has no effect on glial scar formation after transient focal cerebral ischemia in mouse
Jean-Christophe Copin et al.
BRAIN RESEARCH (2007)
Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction
James Haorah et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Physiological and pathological implications of laminins:: From the gene to the protein
Maria-Carolina Paez et al.
AUTOIMMUNITY (2007)
Blood-brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Yuri Persidsky et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2006)
Up-regulation of microglial CD11b expression by nitric oxide
Avik Roy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Metalloproteinases: Mediators of pathology and regeneration in the CNS
VW Yong
NATURE REVIEWS NEUROSCIENCE (2005)
Oxidative stress promotes the increase of matrix metalloproteinases-2 and-9 activities in the feto-placental unit of diabetic rats
MC Pustovrh et al.
FREE RADICAL RESEARCH (2005)
3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease
E Brouillet et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease
WT Lee et al.
PROGRESS IN NEUROBIOLOGY (2004)
Role of microglia in central nervous system infections
RB Rock et al.
CLINICAL MICROBIOLOGY REVIEWS (2004)
Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia
S Rivera et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia
Y Gasche et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)
Expression and activation of matrix metalloproteinase-2 and-9 in rat brain after transient focal cerebral ischemia
AM Planas et al.
NEUROBIOLOGY OF DISEASE (2001)
The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease
M Glass et al.
NEUROSCIENCE (2000)
Share Paper
